Prescriptions of biosimilars in 2021 increase to two-thirds
August 22, 2022
The share of biosimilars in daily therapy doses continued to rise last year. For substances for which biosimilars are available, the average share of biosimilars in Germany increased to 66.3%. The use of biosimilars saved around EUR 1.5 billion in 2021.